A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
To evaluate the potential of adalimumab to inhibit radiographic progression in joint
destruction compared with placebo in adult Japanese subjects with recent onset of rheumatoid
arthritis.